SpineX reports successful first in human study results of SCONE therapy - Video
|
Overview
SCONE, a non-invasive transcutaneous spinal cord neuromodulator is the first of its kind device that is being developed to treat bladder dysfunction.
SpineX, Inc., an early-stage medtech company has announced the publication of new data in the esteemed journal, BioElectric Medicine demonstrating the positive effects of SCONE therapy to treat Urge Urinary Incontinence.
To read the full story, click on the following link:
Speakers
Roshni Dhar, a Mass com graduate with a soft corner for health happenings, joined Medical Dialogues as a news anchor in 2021. Inspired by her mother who is a gynaecologist, she likes to keep herself and the world updated on the occurring in the medical field. She covers various aspects of health news for MDTV at Medical Dialogues. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751